• NICE recommends Janssen’s Crohn’s Disease biological therapy europeanpharmaceuticalreview
    May 03, 2017
    The National Institute for Health and Care Excellence (NICE) has recommended Janssen‘s Stelara (ustekinumab) in its final appraisal determination as a treatment option for adult patients with moderately to severely active Crohn’s disease.
PharmaSources Customer Service